Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01344382 · ClinicalTrials.gov registry record · Phase 1

Family Training Program for Parents of Substance Using Adolescents

A Phase 1 study, sponsored by Treatment Research Institute.

Completed
Registry status
Phase 1
Development phase
126
Enrollment target

NCT01344382 is a Phase 1 study that has completed, run by Treatment Research Institute. The registered enrollment target is 126 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01344382, a Phase 1 study, has completed, sponsored by Treatment Research Institute.

COMPLETED
Registry status
Phase 1
Development phase
126 participants
Enrollment target

Study Summary

This project will modify Community Reinforcement and Family Training (CRAFT; n=15) and Alanon/Naranon Facilitation (ANF; n=15) for use with parents who are concerned about an out-of-treatment adolescent. ANF was selected as a comparison because Alanon and Naranon are the most commonly available method for helping family members. The investigators will compare CRAFT for parents (CRAFT-P) (n=77) and ANF (n=77) to determine if there is a significant difference in adolescent treatment entry. Parents will attend a maximum of 18 sessions with a family specialist and also complete questionnaires periodically over a 12-month period. Parents' adolescents will have the opportunity to participate in the study by completing questionnaires at the same time points as their parent. Our primary hypothesis asks whether participants who are enrolled in the CRAFT-P condition will report more adolescent treatment entry than the ANF condition. Our secondary hypotheses examine: 1) reductions in adolescent substance use and behavior problems in the CRAFT-P group compared to the ANF condition, 2) improvements in parenting skills in the CRAFT-P group compared to the ANF condition and 3) significant pre to post treatment effects for improvements in social functioning, mood, and in parent-adolescent relationship satisfaction.

Interventions

  • BEHAVIORAL Community Reinforcement and Family Training
  • BEHAVIORAL Al-Anon Facilitation

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2011-01
Est. Completion 2016-05
Phase Phase 1

Sponsor

Treatment Research Institute

18 total trials

What the Registry Record Tells You About NCT01344382

The ClinicalTrials.gov registry entry for NCT01344382 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Treatment Research Institute, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Community Reinforcement and Family Training is the first listed.

NCT01344382 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01344382 about?

NCT01344382 is a clinical study titled "Family Training Program for Parents of Substance Using Adolescents". This project will modify Community Reinforcement and Family Training (CRAFT; n=15) and Alanon/Naranon Facilitation (ANF; n=15) for use with parents who are concerned about an out-of-treatment adolescent. ANF was selected as a comparison because Alanon and Naranon are the most commonly available meth...

What is the current status of trial NCT01344382?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 126 participants. The study started on 2011-01. Estimated completion is 2016-05.

What interventions are being tested in trial NCT01344382?

The interventions under investigation include: Community Reinforcement and Family Training (BEHAVIORAL), Al-Anon Facilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01344382?

This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.